Recently, we have demonstrated that ischemic preconditioning (IP) both limits infarct size and decreases internucleosomal DNA fragmentation in rat hearts in vivo, and that there was a direct correlation between myocardial infarct size and DNA fragmentation even after IP. In this study, we examined the ability of IP to attenuate processing and activation of caspase-1 and caspase-3, and cleavage of poly(ADP-ribose) polymerase (PARP), after prolonged ischemia and reperfusion using the same in vivo animal model. Rats that underwent IP and controls (Ctrl) were subjected to 30 min of left coronary artery occlusion followed by 180 min of reperfusion. IP was accomplished by five 5-min cycles of ischemia, each followed by 5 min of reperfusion. The amount of soluble nucleosomes was measured by enzyme-linked immunosorbent assay. Cleavage of caspases-1 and -3, and of one of their substrates PARP, was analyzed by Western blotting. Nucleosomal DNA fragmentation was significantly reduced in ischemic left ventricular (LV) tissue obtained from IP compared with Ctrl animals. The proforms of caspases-1 and -3, and the active form of PARP were not cleaved in the nonischemic LV region of both IP and Ctrl hearts. In contrast, the proform of caspase-3 and the active form of PARP were cleaved in the ischemic LV region of Ctrl hearts, while processing of caspase-1 was increased. Cleavages of caspases-1 and -3, and inactivation of PARP were prevented by IP. The results of this study indicate that IP attenuates both internucleosomal DNA fragmentation and caspases processing, and suggest that the prevention of caspases activation by IP may be important steps in protecting the heart against ischemia / reperfusion injury in vivo.
Ischemic preconditioning attenuates ischemia / reperfusion-induced activation of caspases and subsequent cleavage of poly(ADP-ribose) polymerase in rat hearts in vivo a , b a a
Introduction perfusion in IP rat hearts in vivo;
(ii) the TdT-mediated dUTP nick-end labeling (TUNEL) assay localized fewer Ischemic preconditioning (IP) is one of the most potent and sparsely stained nuclei within the infarct zone of IP mechanisms to protect against myocardial ischemic injury hearts compared with nonIP hearts; (iii) there was a direct [1] [2] [3] [4] [5] [6] [7] [8] . Gottlieb et al. found that apoptosis was reduced by correlation between myocardial infarct size and internupreconditioning in rabbit cardiomyocytes in culture during cleosomal DNA fragmentation [10] . Similar results were metabolic inhibition / recovery [9] . Consistent with this recently reported by Maulik et al. in isolated perfused rat finding, we previously demonstrated that: (i) both internuhearts [11] . Taken together, these data suggest that IP cleosomal DNA fragmentation and infarct size were reduces irreversible ischemic injury in part by decreasing significantly decreased after prolonged ischemia and reapoptosis after prolonged ischemia and reperfusion. Apoptosis is a regulated and energy-requiring mechanism that involves a cascade of biochemical events resulting in cell shrinkage, chromatin condensation, DNÂ fragmentation, and ultimately cell death [12] . Cysteine and were approved by the Committee on Animal Research proteases related to the Caenorhabditis elegans cell death at the University of California, San Francisco, CA, USA. gene ced-3, also called caspases, are considered to be key mediators of the apoptotic machinery [13, 14] . The first mammalian homologue of ced-3 identified was interleukin-2.2. Experimental protocol 1b-converting enzyme (ICE) or caspase-1 according to the new nomenclature [15] . Caspase-1 is expressed in many Animals (five per group) were randomly assigned to one tissues as a proenzyme of 45 kDa, which is processed by of two groups: Ctrl animals with no preconditioning, and proteolytic cleavage to its active form [16] . To date, IP animals. The IP protocol consisted of five consecutive several homologues of caspase-1 have been characterized.
5-min episodes of LCA occlusion, each followed by a Among these, caspase-3 (also called CPP32, Apopain or 5-min period of reperfusion, as previously described [10] . YAMA) is synthesized as an 32 kDa inactive precursor NonIP animals had a comparable 50-min nonischemic requiring cleavage at specific aspartate residues in order to period with the snare occluder open. IP and Ctrl animals be transformed into active protease [17, 18] . One of the were then subjected to 30-min period of LCA occlusion substrates for caspase-3 during apoptosis is the 116 kDa followed by 180 min of reperfusion. Throughout the nuclear DNA repair enzyme, poly(ADP-ribose) polymerase experiments, core body temperature of the animals was (PARP). Cleavage of PARP by either caspase-3 or other monitored by a rectal thermometer and was maintained effector caspases yields an 85 kDa inactive fragment which constant (between 36.8 and 378C) by a heating pad and is considered to be a useful marker for activation of heating lamps. To differentiate between ischemic and caspases during apoptosis [18] [19] [20] .
nonischemic tissue, the LCA was reoccluded after the Recently, Yaoita et al. demonstrated that z-VAD-fmk, a 180-min perfusion period, and 1 ml of phthalocyanine blue caspase inhibitor known to inhibit caspase-1, -3 and -4, dye was injected into the left ventricular (LV) cavity in attenuated ischemia / reperfusion injuries in rat hearts in vivo and allowed to perfuse the nonischemic portions of vivo [21] . Since IP appears to reduce both infarct size (i.e., the heart. The entire heart was excised, rinsed of excess myocyte cell death) and internucleosomal DNA fragmentablue dye, trimmed of right ventricular and atrial tissue, and tion in rat hearts in vivo [10] , we hypothesized that IP may sliced transversely into 5 sections about 2 mm thick. decrease myocyte cell death by attenuating caspases Samples from both ischemic (unstained) and nonischemic activation. To test our hypothesis, we examined the ability (blue-stained) cardiac tissue were collected to assess DNA of IP to attenuate processing and activation of caspase-1 fragmentation by enzyme-linked immunosorbent assay and caspase-3, and subsequent cleavage of PARP, after (ELISA) and caspase-1, caspase-3 and PARP cleavage by prolonged ischemia and reperfusion in our in vivo animal Western blotting as described below. model.
ELISA

Materials and methods
The amount of soluble mono-and oligonucleosomes 2.1. Animal model of acute myocardial ischemia and was measured using an ELISA kit (Boehringer Mannheim) reperfusion as previously described [10] . Transmural samples of fresh tissue (625 mg) from completely normal areas (central IP and control (Ctrl) animals were subjected to a portion of the septum) and ischemic areas (central portion protocol of ischemia and reperfusion described previously of the LV free wall, halfway from the edge of the septum) [5, 6, 10] . Briefly, female Sprague-Dawley rats weighing were isolated from one slide with the phthalocyanine blue 225-250 g were anesthetized with intraperitoneal pendye perfusion as a guide, washed of blood, homogenized in tobarbital (40 mg / kg) and ventilated via a tracheostomy on tissue grinder and incubated for 30 min at room temperaa Harvard rodent respirator (tidal volume 0.5 to 1.5 ml; ture in 400 ml lysis buffer supplied with the kit. The respiratory rate 95-105 breaths per min). A midline homogenate was centrifuged at 13 000 g for 20 min. The sternotomy was performed, and a reversible coronary supernatant (i.e., cytosolic fraction) was further diluted artery snare occluder was placed around the proximal left 50-fold in phosphate-buffered saline buffer (137 mmol / l coronary artery (LCA). A 1 s test occlusion, too short to NaCl; 2.7 mmol / l KCl; 4.3 mmol / l Na HPO ?7H O; 1.4 2 4 2 induce preconditioning, was performed to visually test the mmol / l KH PO pH 7.4) and directly used as antigen 2 4 occluder and its positioning. After a subsequent 20-min source in the sandwich ELISA. Incubation buffer instead stabilization period, all animals were then randomly subof sample solution and DNA-histone complex included in jected to one of the two protocols described bellow. All the kit were used as background control and positive experiments in this study were performed in accordance control, respectively. Three separate spectrophotometric with the guidelines for animal research from the National measurements (A405 /A490) were averaged, and the backInstitutes of Health (NIH publication 85-23, revised 1985) , ground value of the immunoassay was subtracted from each of these averages. The positive control was used as 3. Results internal control for daily variability of the assay.
3.1. Quantification of DNA fragmentation
Western blotting
Quantitative analysis of soluble mono-and oligonucleosomes was performed by ELISA both in Ctrl and IP To detect processing of caspase-1 and -3 (ICE and animals. As illustrated in Fig. 1 To characterize the effect of IP on some of the comphoresis (SDS-PAGE) (7.5%, 15%) and transferred to ponents of the apoptotic pathway, we performed Western Immobilon-P membranes (Millipore). Separate Western blot analysis for caspases-1 and -3. Both caspases are blots were performed using two different antibodies: (1) an constitutively expressed in cells as inactive proenzymes of antihuman caspase-1 rabbit polyclonal antibody (1:1000; 45 kDa and 32 kDa, respectively. These proenzymes need Upstate Biotechnology) that recognizes the proenzyme of to be cleaved at specific aspartate residues to generate two 45 kDa and the p20 subunit of active caspase-1; (2) an smaller active subunits which oligomerize to form an antihuman caspase-3 rabbit polyclonal antibody (1:300 active protease complex. As illustrated in Fig. 2A , all dilution; Upstate Biotechnology) that recognizes caspase-3 tissue samples (n55) showed an immunoreactive band of precursor (32 kDa) but failed to recognize the p12 subunit 45 kDa corresponding to the proform of caspase-1. Nonof caspase-3 (manufacturer's information); and (3) an antihuman PARP rabbit polyclonal antibody (1:750 dilution; Upstate Biotechnology) that recognizes both the 116 kDa of PARP and its 85 kDa fragment. The species cross-reactivity of anticaspase-3 and antiPARP have been tested in rat PC-12 cells, while the immunizing sequence used to raise the anticaspase-1 has 100% homology to the rat sequence [22] . Western blots were incubated with the appropriate antibody and then washed in Tris-buffered saline containing 0.1% Tween 20. Antigen-antibody complexes were detected with horseradish peroxidase-coupled secondary antibodies and the enhanced chemiluminescence system (Renaissance; NEN). Finally, the blots were exposed to reflection NEF films (NEN). Autoradiographs of antiPARP Western blot were analyzed by densitometry and quantified using Intelligent Quantifier (BioImage) software. (Fig. 2B, lanes 1 and 3) . In contrast, the inactive proform of caspase-3 was markedly reduced in the ischemic LV tissue obtained from Ctrl animals (lane 2), most likely due to proteolytic cleavage of this proform to generate the active subunits. This cleavage of the inactive proform of caspase-3 was prevented by IP (lane 4).
Statistical analysis
Cleavage of PARP
PARP, one of the known substrates of caspase-3, is a nuclear enzyme involved in DNA repair. During the apoptotic process, PARP is inactivated by a single proteolytic cleavage of the 116 kDa active enzyme that generates a 85 kDa fragment. As illustrated on Fig. 3A , the 116 kDa form was uncleaved in all nonischemic LV tissue samples (lanes 1, 3, 5 and 7). In contrast, this active form was almost completely cleaved and, in turn, the 85 kDa fragment was more abundant in the ischemic LV tissue obtained from Ctrl animals (lanes 2 and 8). This cleavage and inactivation of PARP was reduced by IP (lanes 4 and 6).
Autoradiographs of Western blots were also analyzed by densitometry to determine the relative intensity of the 116 and 85 kDa bands. The relative cleavage and inactivation of PARP is shown in Fig. 3B caspase-1 (p45) and caspase-3 (p32) and the subunits corresponding to each active enzyme (p20) and (p12), respectively. The p12 subunit of 10.863.7%; n55; p5NS). These results suggest that caspase-3 was not reproducibly detected. Note that both the increase of caspase activity plays a role in myocyte cell death after p20 subunit of active caspase-1 (A) and the disappearance of the proform ischemia and reperfusion. ischemic and ischemic LV tissue obtained from both Ctrl 4. Discussion and IP animals expressed similar amount of this proform. However, the active subunit of 20 kDa was only highly
In this present study, we found that caspase-1 and detectable in the ischemic LV tissue obtained from Ctrl caspase-3 activation, and PARP cleavage were early events animals (lane 2) while in the nonischemic LV tissue that accompany internucleosomal DNA fragmentation obtained from both Ctrl and IP animals, this band was faint induced by prolonged ischemia and reperfusion in rat mentation, a hallmark of apoptosis, was restricted in the infarcted area after prolonged ischemia and reperfusion in rat hearts in vivo [25] , which was confirmed by the TUNEL assay [10] . Moreover, we found a close correlation between infarct size and degree of internucleosomal DNA fragmentation in this in vivo model [10] . However, our results did not allow a conclusion regarding the relationship between apoptotic cell death and necrosis.
In the present study, we demonstrate that prolonged ischemia followed by reperfusion is accompanied by processing of the apoptotic proteases, caspases-1 and -3, and inactivation of one of their substrates, PARP, a nuclear DNA repair enzyme, in the ischemic portion of nonIP rat hearts in vivo. The generation of the active form of caspase-1 was always associated with the disappearance of the proform of caspase-3 and both the inactivation of its substrate PARP and DNA fragmentation in the ischemic LV tissue obtained from Ctrl animals. Taken together with our previous data, these results suggest that activation of caspases-1 and -3 following ischemia / reperfusion may lead to inactivation of PARP, increased DNA fragmentation, and finally cell death. Since caspases are known to interact each other and act as complexes, it is highly possible that ischemia / reperfusion regulates not only caspases-1 and -3 activation but also other cysteine proteases of the effector phase of apoptosis. Furthermore, Black et al. recently colocalized caspase-3 with apoptotic myocytes after in vivo myocardial ischemia / reperfusion in rats [26] . All these findings support the hypothesis that ischemia followed by reperfusion is a noxious stimulus able to activate the physiological cell death mechanism in suggesting that apoptosis of cardiomyocytes may be Further studies need to be performed in order to demonstrate if such signaling pathways are directly involved in Although it has been accepted for almost a century that activation of caspases in the ischemic and reperfused necrosis (i.e., a catastrophic metabolic failure resulting myocardium. directly from severe damage) was the only mechanism of cardiomyocyte cell death during ischemia, recent observations support the evidence that apoptosis may be the 4.2. Prevention of ischemia /reperfusion-induced prominent form of ischemia-related cell death in the heart apoptosis by IP [23, 24] . Consistent with this new and attractive concept, we reported previously that internucleosomal DNA fragIt has been demonstrated that brief periods of acute myocardial ischemia (i.e., IP) protect the heart against plays in the regulation of cell death. For example, it has subsequent episodes of prolonged ischemia by delaying been suggested that apoptosis may be regulated in part by lethal cell injury, thereby limiting infarct size [1] [2] [3] [4] [5] [6] [7] [8] . The an imbalance between different MAPK pathways in differmechanism by which transient ischemia prevent ischemic ent cell systems [40, 41] . Previous studies have also myocyte cell death remains not well understood. Recently, examined the contribution of neutrophils to apoptosis in we demonstrated that both DNA fragmentation (i.e., reperfused myocardium in vivo [42] [43] [44] . According to this nucleosome-sized DNA ladders, soluble nucleosomes and hypothesis, Wang et al. have recently suggested that IP DNA-nick end labeling) and infarct size were significantly may attenuate myocardial apoptosis in part by inhibiting decreased after prolonged ischemia and reperfusion in IP polymorphonuclear neutrophil activation [33] . Implication rat hearts in vivo using the same experimental protocol of such mechanisms in the regulation of caspases activity [10] . We observed a close correlation between infarct size in the IP heart needs to be further studied. and the amount of internucleosomal DNA fragmentation in this animal model. Moreover, the correlation was maintained after IP [10] . These results were consistent with a 5. Conclusion previous report by Gottlieb et al. showing that IP was able to prevent programmed cell death in vitro [9] . On the basis This study indicates that both caspases-1 and caspase-3 of these findings, we suggested that IP reduces irreversible activation, and PARP cleavage are early events that ischemic injury (i.e., myocyte cell death) in part by accompany internucleosomal DNA fragmentation induced preventing apoptosis after prolonged ischemia and reperfuby prolonged ischemia and reperfusion in rat hearts in sion in vivo. Since then, Maulik et al. demonstrated that vivo. Furthermore, we demonstrate for the first time that apoptotic cell death and DNA fragmentation were comthese events are highly prevented by IP. These results pletely abolished by IP in isolated perfused rat hearts [11] .
indicate that IP attenuates both internucleosomal DNA Similar findings were also recently demonstrated by Wang fragmentation and caspases processing, and suggest that et al. in dog hearts [33] .
the prevention of caspases activation by IP may be Continuing the same experimental protocol, we report important steps in protecting the heart against ischemia / here that IP attenuates processing of both caspases-1 and reperfusion injury in vivo. -3, and cleavage of PARP in rat hearts in vivo. Since apoptotic proteases are considered to be key components in the effector phase of apoptosis, these results support our
